The importance of the NKG2A/HLA-E interaction has been demonstrated for other diseases, e.g., within a humanized, post-transplantation model, which demonstrated that re-constituted NKG2A+ NK cells were able to kill human primary leukemia cells when mice were injected with an anti-human NKG2A antibody (53). Here, KLRC1 is linked to leukemia.